Advertisement

Orofacial Pain in Cancer

  • Gary D. KlasserEmail author
  • Joel Epstein
Chapter

Abstract

  • Mild-to-moderate pain is present in the majority of HNC patients at the time of diagnosis.

  • Orofacial pain due to HNC is the most common reason patients seek diagnosis.

  • Pain arising in cancer patients usually have a multifactorial etiology and require a multidisciplinary management approach.

  • The approach to treatment of pain from malignant origin and all cancer therapies that are pain focused must follow guidelines of WHO analgesic ladder, including topical therapy for oropharyngeal pain, and use of adjunctive medications and pain management strategies.

References

  1. 1.
    Potter J, Higginson IJ, Scadding JW, Quigley C. Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med. 2003;96(8):379–83.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):56–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Holtan A, Aass N, Nordoy T, Haugen DF, Kaasa S, Mohr W, et al. Prevalence of pain in hospitalised cancer patients in Norway: a national survey. Palliat Med. 2007;21(1):7–13.CrossRefPubMedGoogle Scholar
  4. 4.
    Ripamonti C, Zecca E, Brunelli C, Groff L, Boffi R, Caraceni A, et al. Pain experienced by patients hospitalized at the National Cancer Institute of Milan: research project “towards a pain-free hospital”. Tumori. 2000;86(5):412–8.PubMedGoogle Scholar
  5. 5.
    Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82(3):263–74.CrossRefPubMedGoogle Scholar
  6. 6.
    Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64(1):107–14.CrossRefPubMedGoogle Scholar
  7. 7.
    Epstein JB, Jones CK. Presenting signs and symptoms of nasopharyngeal carcinoma. Oral Surg Oral Med Oral Pathol. 1993;75(1):32–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Mantyh PW. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 2014;8(2):83–90.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol (R Coll Radiol). 2011;23(6):387–92.CrossRefGoogle Scholar
  10. 10.
    Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF, et al. Advances in cancer pain from bone metastasis. Drug Des Dev Ther. 2015;9:4239–45.Google Scholar
  11. 11.
    Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL. Mechanism of cancer pain. Mol Interv. 2010;10(3):164–78.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–84.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Dubner R. The neurobiology of persistent pain and its clinical implications. Suppl Clin Neurophysiol. 2004;57:3–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14(4):217–31.CrossRefPubMedGoogle Scholar
  15. 15.
    Okuse K. Pain signalling pathways: from cytokines to ion channels. Int J Biochem Cell Biol. 2007;39(3):490–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Oranger A, Carbone C, Izzo M, Grano M. Cellular mechanisms of multiple myeloma bone disease. Clin Dev Immunol. 2013;2013:289458.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015;27(3):159–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218–28.CrossRefPubMedGoogle Scholar
  19. 19.
    Daughaday WH, Deuel TF. Tumor secretion of growth factors. Endocrinol Metab Clin N Am. 1991;20(3):539–63.Google Scholar
  20. 20.
    Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nat Rev Cancer. 2002;2(3):201–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Sanchez OH. Insights into novel biological mediators of clinical manifestations in cancer. AACN Clin Issues. 2004;15(1):112–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413(6852):203–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Sutherland SP, Cook SP, McCleskey EW. Chemical mediators of pain due to tissue damage and ischemia. Prog Brain Res. 2000;129:21–38.CrossRefPubMedGoogle Scholar
  25. 25.
    Boyette-Davis JA, Walters ET, Dougherty PM. Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag. 2015;5(4):285–96.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol. 2010;30(3):273–86.CrossRefPubMedGoogle Scholar
  27. 27.
    Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010;28(1):217–34.CrossRefPubMedGoogle Scholar
  28. 28.
    Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol. 2010;46(2):77–81.CrossRefPubMedGoogle Scholar
  29. 29.
    Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, et al. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer. 2015;67(2):339–53.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Alvarez-Camacho M, Gonella S, Ghosh S, Kubrak C, Scrimger RA, Chu KP, et al. The impact of taste and smell alterations on quality of life in head and neck cancer patients. Qual Life Res. 2016;25(6):1495–504.Google Scholar
  31. 31.
    Gellrich NC, Schimming R, Schramm A, Schmalohr D, Bremerich A, Kugler J. Pain, function, and psychologic outcome before, during, and after intraoral tumor resection. J Oral Maxillofac Surg. 2002;60(7):772.CrossRefPubMedGoogle Scholar
  32. 32.
    Weymuller EA, Yueh B, Deleyiannis FW, Kuntz AL, Alsarraf R, Coltrera MD. Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg. 2000;126(3):329–35.CrossRefPubMedGoogle Scholar
  33. 33.
    Al-Ansari S, Zecha JA, Barasch A, de Lange J, Rozema FR, Raber-Durlacher JE. Oral mucositis induced by anticancer therapies. Curr Oral Health Rep. 2015;2(4):202–11.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Boers-Doets CB, Raber-Durlacher JE, Treister NS, Epstein JB, Arends AB, Wiersma DR, et al. Mammalian target of rapamycin inhibitor-associated stomatitis. Future Oncol. 2013;9(12):1883–92.CrossRefPubMedGoogle Scholar
  35. 35.
    Watters AL, Epstein JB, Agulnik M. Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol. 2011;47(6):441–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Jackson LK, Johnson DB, Sosman JA, Murphy BA, Epstein JB. Oral health in oncology: impact of immunotherapy. Support Care Cancer. 2015;23(1):1–3.CrossRefPubMedGoogle Scholar
  37. 37.
    Miaskowski C. Biology of mucosal pain. J Natl Cancer Inst Monogr. 2001;29:37–40.CrossRefGoogle Scholar
  38. 38.
    Van Sebille YZ, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr Oncol Rep. 2015;17(11):50.CrossRefPubMedGoogle Scholar
  39. 39.
    Mallick S, Benson R, Rath GK. Radiation induced oral mucositis: a review of current literature on prevention and management. Eur Arch Otorhinolaryngol. 2016;273(9):2285–93.Google Scholar
  40. 40.
    Vadalouca A, Raptis E, Moka E, Zis P, Sykioti P, Siafaka I. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract. 2012;12(3):219–51.CrossRefPubMedGoogle Scholar
  41. 41.
    Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci. 2001;2(2):83–91.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Louisiana State University Health Sciences Center, School of Dentistry, Department of Diagnostic SciencesNew OrleansUSA
  2. 2.Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Health SystemLos AngelesUSA
  3. 3.Division of Otolaryngology and Head and Neck SurgeryCity of HopeDuarteUSA

Personalised recommendations